Rimonabant treatment partly attenuates skeletal muscle loss following immobilization in young and old sarcopenic male mice
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2025
DOI: 10.1093/gerona/glaf189 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2025. Verfasst von Sebastiaan Dalle und 6 weiteren Autor:innen. Beteiligte Einrichtung: Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Rimonabant, Sarcopenia, Muscle, Skeletal, Pyrazoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Research Foundation Flanders.
Abstract (Originalsprache)
Muscle tissue is important for locomotion and metabolic health. Muscle disuse (eg, postoperative) occurs more often in older adults and results in rapid muscle wasting. Currently, there is no effective treatment to combat immobilization-induced atrophy, which is why novel therapeutic strategies are needed. Antagonism of cannabinoid receptor 1 (CB1) can stimulate muscle protein synthesis, thereby protecting against glucocorticosteroid-induced atrophy. However, its therapeutic potential against (age-related) immobilization-induced atrophy remains unknown. Therefore, we investigated the effect of CB1 antagonism on muscle responses following immobilization in young and old, sarcopenic male mice. One hind limb of young and old male C57BL/6 mice was immobilized for 5 days, during which they were treated with the CB1 antagonist Rimonabant (10 mg/kg per day) or vehicle. Hereafter, mice were euthanized and muscles were collected. Endocannabinoid, anabolic, and catabolic markers were analyzed in the gastrocnemius muscle via western blotting. Rimonabant attenuated immobilization-induced gastrocnemius muscle mass loss in both ages (−7.9% vs vehicle: −11.2%; P = .0027). Immobilization increased expression of the anabolic regulators (p-S6rp, p-4E-BP1), and of the catabolic markers (LC3b-II/I, MAFbx), which remained unaffected by Rimonabant treatment. Surprisingly, Rimonabant amplified the immobilization-induced decrease in muscle protein synthesis (−45.8% vs vehicle: −27%; P = .0180) to a larger extent in young vs old mice (P = .0005). Immobilization decreased the expression of the enzyme NAPE-PLD, responsible for the synthesis of the endocannabinoid anandamide, whereas its degrading enzyme FAAH was higher expressed. More research is needed to unravel the mechanisms underlying the muscle-sparing effect of Rimonabant and anandamide’s role in muscle degeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Leuven, Belgium.
- MOVANT Research Group, Department of Rehabilitation Sciences and Physiotherapy, University of Antwerp, Antwerp, Belgium.
- Endocrinology, Diabetes, and Nutrition Unit, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Woluwe-Saint-Lambert, Belgium.
ORCID-Profile: Sebastiaan Dalle
Förderung
- Research Foundation Flanders
Zitieren
APA
Dalle, S., Vanderbeke, K., Schouten, M., Ramaekers, M., Abou-Samra, M., Costamagna, D., & Koppo, K. (2025). Rimonabant treatment partly attenuates skeletal muscle loss following immobilization in young and old sarcopenic male mice. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glaf189
Vancouver
Dalle S, Vanderbeke K, Schouten M, Ramaekers M, Abou-Samra M, Costamagna D, et al. Rimonabant treatment partly attenuates skeletal muscle loss following immobilization in young and old sarcopenic male mice. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025. doi:10.1093/gerona/glaf189
BibTeX
@article{Dalle2025,
author = {Dalle, Sebastiaan and Vanderbeke, Kaat and Schouten, Moniek and Ramaekers, Monique and Abou-Samra, Michel and Costamagna, Domiziana and Koppo, Katrien},
title = {Rimonabant treatment partly attenuates skeletal muscle loss following immobilization in young and old sarcopenic male mice},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2025},
doi = {10.1093/gerona/glaf189}
}
EUVIMED